Overview
How Can You Unlock the Opportunities of Theranostics?
What: MIM Software SNNMI 2025 Satellite Symposium: Imaging Biomarkers in the Era of Theranostics
When: Tuesday, June 24, 2025 | 6:45 -7:45 a.m. CT
Where: New Orleans Convention Center
900 Convention Center Blvd
New Orleans, LA 70130
Room: R02-R03 - Level 2
More Info: Imaging of Theranostic agents promises to answer key clinical questions: Is my patient a good candidate for the therapy? Is my patient likely to respond or experience radiation-induced toxicity? Is my patient responding to treatment so far?
In the MIM Software Satellite Symposium at SNMMI, learn about how total tumor burden quantification and dosimetry can be practically incorporated into your clinical routine and enable you to make more informed decisions for your patients.
Breakfast provided!
Speakers

Julia Brosch-Lenz, PhD
Lead Medical Physicist - Radiopharmaceutical Therapy Research | Institute of Nuclear Medicine

Danny Mena Cortes, MD, MBA
Chief of Nuclear Medicine Dept. | Oncología San José, México
Additional Remarks from:
- Andy Nelson
CEO | MIM Software, a GE HealthCare Company - Jean-Luc Procaccini
President & CEO, Molecular Imaging & Computed Tomography | GE HealthCare